287 related articles for article (PubMed ID: 16272533)
1. Intraabdominal zygomycosis caused by Syncephalastrum racemosum infection successfully treated with partial surgical debridement and high-dose amphotericin B lipid complex.
Schlebusch S; Looke DF
J Clin Microbiol; 2005 Nov; 43(11):5825-7. PubMed ID: 16272533
[TBL] [Abstract][Full Text] [Related]
2. Abdominal wall mucormycosis successfully treated with amphotericin and itraconazole.
Hunter AJ; Bryant RE
J Infect; 2002 Apr; 44(3):203-4. PubMed ID: 12099754
[TBL] [Abstract][Full Text] [Related]
3. Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantation.
Jantunen E; Kolho E; Ruutu P; Koukila-Kähkölä P; Virolainen M; Juvonen E; Volin L
Bone Marrow Transplant; 1996 Jul; 18(1):229-30. PubMed ID: 8832023
[TBL] [Abstract][Full Text] [Related]
4. Palate ulcer due to mucormycosis.
Kyrmizakis DE; Doxas PG; Hajiioannou JK; Papadakis CE
J Laryngol Otol; 2002 Feb; 116(2):146-7. PubMed ID: 11827594
[TBL] [Abstract][Full Text] [Related]
5. Favorable outcome of amphotericin B treatment of zygomycotic necrotizing fascitis caused by Apophysomyces elegans.
Devi SC; Kanungo R; Barreto E; Thomas AG; Shashikala N; Srinivasan S; Anitha PK
Int J Dermatol; 2008 Apr; 47(4):407-9. PubMed ID: 18377611
[No Abstract] [Full Text] [Related]
6. Outcomes of invasive zygomycosis infections in renal transplant recipients.
Forrest GN; Mankes K
Transpl Infect Dis; 2007 Jun; 9(2):161-4. PubMed ID: 17462005
[TBL] [Abstract][Full Text] [Related]
7. Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient.
Crompton JA; Alexander D; Somerville T; Shihab FS
Transpl Infect Dis; 2004 Dec; 6(4):183-7. PubMed ID: 15762937
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice.
Spellberg B; Fu Y; Edwards JE; Ibrahim AS
Antimicrob Agents Chemother; 2005 Feb; 49(2):830-2. PubMed ID: 15673781
[TBL] [Abstract][Full Text] [Related]
9. Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease.
Roy V; Ali LI; Carter TH; Selby GB
J Infect; 2000 Nov; 41(3):273-5. PubMed ID: 11120619
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B lipid complex for the treatment of recurrent blastomycosis of the brain in a patient previously treated with itraconazole.
Cook PP
South Med J; 2001 May; 94(5):548-9. PubMed ID: 11372815
[TBL] [Abstract][Full Text] [Related]
11. Invasive mucormycosis of the maxillary sinus: extensive destruction with an indolent presentation.
Odessey E; Cohn A; Beaman K; Schechter L
Surg Infect (Larchmt); 2008 Feb; 9(1):91-8. PubMed ID: 18363473
[TBL] [Abstract][Full Text] [Related]
12. Severe cutaneous zygomycosis: evaluation of treatment with high doses of liposomal amphotericin B in a one-year old child.
Bandettini R; Tuo P; Tamisani AM; Di Marco E; Mantero E
J Chemother; 2007 Jun; 19(3):347-9. PubMed ID: 17594934
[No Abstract] [Full Text] [Related]
13. Resolution of rhinocerebral zygomycosis associated with adjuvant administration of granulocyte-macrophage colony-stimulating factor.
Garcia-Diaz JB; Palau L; Pankey GA
Clin Infect Dis; 2001 Jun; 32(12):e145-50. PubMed ID: 11360225
[TBL] [Abstract][Full Text] [Related]
14. Successful medical management of isolated renal zygomycosis: case report and review.
Weng DE; Wilson WH; Little R; Walsh TJ
Clin Infect Dis; 1998 Mar; 26(3):601-5. PubMed ID: 9524830
[TBL] [Abstract][Full Text] [Related]
15. Mucormycosis in a Non-Hodgkin Lymphoma Patient Caused by Syncephalastrum racemosum: Case Report and Review of Literature.
Rodríguez-Gutiérrez G; Carrillo-Casas EM; Arenas R; García-Méndez JO; Toussaint S; Moreno-Morales ME; Schcolnik-Cabrera AA; Xicohtencatl-Cortes J; Hernández-Castro R
Mycopathologia; 2015 Aug; 180(1-2):89-93. PubMed ID: 25736172
[TBL] [Abstract][Full Text] [Related]
16. Primary Cutaneous Mucormycosis Due to Saksenaea vasiformis in an Immunocompetent Patient.
Coronel-Pérez IM; Rodríguez-Rey EM; Castilla-Guerra L; Domínguez MC
Actas Dermosifiliogr; 2015; 106(6):516-8. PubMed ID: 25661417
[No Abstract] [Full Text] [Related]
17. Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.
Singhal S; Ellis RW; Jones SG; Miller SJ; Fisher NC; Hastings JG; Mutimer DJ
Liver Transpl; 2000 Sep; 6(5):588-95. PubMed ID: 10980058
[TBL] [Abstract][Full Text] [Related]
18. Controlled trials of amphotericin B lipid complex and other lipid-associated formulations.
Winston DJ; Schiller GJ
Clin Infect Dis; 2000 Jan; 30(1):236-7. PubMed ID: 10619780
[No Abstract] [Full Text] [Related]
19. Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registry.
Pappas PG
Clin Infect Dis; 2005 May; 40 Suppl 6():S379-83. PubMed ID: 15809923
[No Abstract] [Full Text] [Related]
20. Worsening of endogenous Candida albicans endophthalmitis during therapy with intravenous lipid complex amphotericin B.
Virata SR; Kylstra JA; Brown JC; Wohl DA; Cohen MS
Clin Infect Dis; 1999 May; 28(5):1177-8. PubMed ID: 10452666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
